"The United States has a robust surveillance system in place, including through clinical testing and wastewater analysis. We continue to encourage those at high risk to get vaccinated with the Jynneos mpox vaccine, which has been demonstrated to be safe and highly effective at preventing severe disease from mpox."
"Despite the availability of the vaccine, the U.S. government's response to the 2022 mpox outbreak faced significant criticism, including poor communication, inadequate coordination among agencies, and insufficient outreach to vulnerable populations."
"The risk of Clade I mpox to the general public in the United States remains very low, with no known cases reported domestically, ensuring that we are prepared to manage potential cases swiftly."
Collection
[
|
...
]